How Digital Can Improve Regulatory Compliance for Life Sciences

Today, life sciences organizations (LSOs) are increasingly working with global partners and service providers in extended networks. How does this affect regulatory compliance?

Snapshot Insights

Snapshot Insights,

It is critical that all employees are fully aware of, and adhere to, all regulatory compliance requirements. Even though regulatory compliance training is mandatory before the start of any LSO’s IT project, the mandate often stops at the “how” part of the compliance process rather than including the “why.”

Blog: The 3 Steps of Succeeding with AI

The issue assumes greater significance in contract research organizations (CROs)/contract manufacturing organizations (CMOs) and IT service providers. Here, individuals often move from varied and nonregulated industries into LSOs, wherein the lack of “control” over their activities and deliverables can result in noncompliance. 

To effectively ensure that critical applications which manage food, drugs, patient and clinical data (GxP applications) comply with industry and government regulations, LSOs must focus on established standards such as Title 21 Code of Federal Regulations (CFR) Part 11 (Electronic Records and Electronic Signatures) in processing electronic data that U.S. FDA predicate rules1 require. They must also maintain good automated manufacturing practices (GAMP) and validate IT applications to comply with industry and mandatory regulation.

Fill in the form to download our white paper that identifies and describes the actions LSOs must take regarding their people and process documentation to ensure sustained compliance. Meanwhile, you might also be interested in learning more about how 

Related Publications

Crafting the Modern Manufacturing Enterprise

To get ahead in the industrial space amid the prolonged pandemic, manufacturers must embrace holistic agility and resilience, and democratize access to applications and data. This whitepaper provides a roadmap ahead.

e-Book: Covid-19, a Manufacturing Wakeup Call

Covid-19 served as a wake-up call to manufacturers – one that has accelerated the need for digitalization. To find out what technology investments will propel manufacturers forward, we conducted ESI ThoughtLab. Learn more in our e-Book.

5 Tech Trends That Will Change Life Sciences

Five technology trends – AI and automation, human augmentation, edge analytics/ processing, data ownership and protection, and the intermingling of products and services – are currently changing the life sciences industry.

How AI can Accelerate Diabetic Retinopathy Detection

WHO believes that 80% of all visual impairment caused by Diabetic Retinopathy can be cured with regular screening and early detection. Follow our journey in developing an AI-based diagnostic tool to speed up DR identification.